Search Results - "Arrighetti, N"
-
1
Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment
Published in The Journal of pharmacology and experimental therapeutics (01-03-2014)“…Since response to platinum-based therapy in non-small-cell lung cancer (NSCLC) is poor, the present study was designed to rationally identify novel drug…”
Get more information
Journal Article -
2
236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma
Published in European journal of cancer (1990) (01-10-2024)Get full text
Journal Article -
3
Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES)
Published in European journal of cancer (1990) (01-10-2022)Get full text
Journal Article -
4
Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells
Published in Biochemical pharmacology (01-03-2022)“…[Display omitted] Deubiquitinases (DUBs) mediate the removal of ubiquitin from diverse proteins that participate in the regulation of cell survival, DNA damage…”
Get full text
Journal Article -
5
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
Published in Frontiers in cell and developmental biology (2022)“…The identification of therapeutic approaches to improve response to platinum-based therapies is an urgent need for ovarian carcinoma. Deubiquitinases are a…”
Get full text
Journal Article